BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15197336)

  • 1. Implications of apoptosis regulators in tumorigenesis.
    Malaguarnera L
    Cancer Metastasis Rev; 2004; 23(3-4):367-87. PubMed ID: 15197336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Better understanding of the biology of cancer cells].
    Klein G
    Ugeskr Laeger; 2000 Sep; 162(39):5199-204. PubMed ID: 11043045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.
    Schattenberg JM; Schuchmann M; Galle PR
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():213-9. PubMed ID: 21199533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Better understanding of the biology of cancer cells].
    Klein G
    Lakartidningen; 2000 Jul; 97(28-29):3260-4. PubMed ID: 10997012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitization of solid tumor cells by alteration of their susceptibility to apoptosis.
    Cree IA; Knight L; Di Nicolantonio F; Sharma S; Gulliford T
    Curr Opin Investig Drugs; 2002 Apr; 3(4):641-7. PubMed ID: 12090737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell signaling and cancer-possible targets for therapy.
    Wenner CE
    J Cell Physiol; 2010 May; 223(2):299-308. PubMed ID: 20127706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of apoptosis during development of colorectal cancer.
    Bedi A; Pasricha PJ; Akhtar AJ; Barber JP; Bedi GC; Giardiello FM; Zehnbauer BA; Hamilton SR; Jones RJ
    Cancer Res; 1995 May; 55(9):1811-6. PubMed ID: 7728743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The malignant transformation event as a clonal transformation of apoptosis to anti-apoptosis pathways and of cell cycle dynamics.
    Agius LM
    Med Hypotheses; 2004; 62(6):914-8. PubMed ID: 15142647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death.
    Coates JM; Galante JM; Bold RJ
    J Surg Res; 2010 Dec; 164(2):301-8. PubMed ID: 20031162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB in solid tumors.
    Pacifico F; Leonardi A
    Biochem Pharmacol; 2006 Oct; 72(9):1142-52. PubMed ID: 16956585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.
    Li QX; Yu DH; Liu G; Ke N; McKelvy J; Wong-Staal F
    Cell Death Differ; 2008 Aug; 15(8):1197-210. PubMed ID: 18437165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis and non-apoptotic deaths in cancer development and treatment response.
    de Bruin EC; Medema JP
    Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [p53 mutations and their role in tumorigenesis].
    Tsuchida N; Munirajan AK
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1567-75. PubMed ID: 9279083
    [No Abstract]   [Full Text] [Related]  

  • 18. Colon cancer and apoptosis.
    Huerta S; Goulet EJ; Livingston EH
    Am J Surg; 2006 Apr; 191(4):517-26. PubMed ID: 16531147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological principles for multimodal therapy approaches].
    Schackert HK; Bornhäuser M; Dörr W; Frank S
    Zentralbl Chir; 2000; 125(4):306-14. PubMed ID: 10829309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
    Johnson TM; Attardi LD
    Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.